Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Personalis, Inc. reported the full year of 2022 results: revenue in the range of $63.0 million to $64.0 million, net income in the range of $111.0 million to $114.0 million. Guidance initiated.
- Period
- the full year of 2022
- Revenue
- in the range of $63.0 million to $64.0 million
- Net income
- in the range of $111.0 million to $114.0 million
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Full Year 2022 Outlook Personalis expects the following for the full year of 2022: • Total company revenue is expected to be in the range of $63.0 million to $64.0 million • Revenue from biopharma and all other customers, excluding the VA MVP, is expected to be in the range of $55.5 million to $56.5 million • Net loss is expected to be in the range of $111.0 million to $114.0 million
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Personalis, Inc. reported the third quarter ended September 30, 2022 results: revenue $14.9 million, net income $26.5 million, EPS $0.58.
- Period
- the third quarter ended September 30, 2022
- Revenue
- $14.9 million
- Net income
- $26.5 million
- EPS
- $0.58
- Result
- reported results
Exact text from the filing
Revenue was $14.9 million in the three months ended September 30, 2022 • Gross margin was 16.7% in the three months ended September 30, 2022 • Operating expenses were $29.7 million in the three months ended September 30, 2022 • Net loss was $26.5 million in the three months ended September 30, 2022, and net loss per share was $0.58 based on a weighted-average basic and diluted share count of 45.9 million
View on SEC.gov